Federal Court of Justice (BGH) confirms additional payments for former shareholders of STADA Arzneimittel AG
Issuer: Schutzgemeinschaft der Kapitalanleger e.V. / Key word(s): Legal Matter/Offer
08.02.2024 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.*Federal Court of Justice (BGH) confirms additional payments for former shareholders of STADA Arzneimittel AG*
SdK initiates legal action
On July 19, 2017, Nidda Healthcare Holding AG, a joint venture of the international financial investors Bain Capital and Cinven Partners, submitted a voluntary public takeover offer to the shareholders of STADA Arzneimittel AG to acquire their shares at a price of € 66.25 per share. Within the acceptance period (until the end of August 16, 2017), the bidder's offer was accepted by 63.76 % of STADA shareholders and within a further acceptance period (until September 1, 2017) by a further 0.11 % of STADA shareholders. The bidder thus achieved a tender volume, including shares held by STADA, of approx. 63.87 % of STADA's share capital and voting rights. On August 30, 2017, a shareholder holding 8,265,142 shares (13.26 % of the shares and voting rights) agreed to a domination and profit and loss transfer agreement between Nidda Healthcare and STADA if the amount of the compensation under the domination and proft and loss transfer agreement is at least EUR 74.40 per STADA share.
Several former shareholders of STADA, who had accepted the lower takeover offer, filed a lawsuit against the bidder demanding the difference between the offer price and the compensation under the domination and profit and loss transfer agreement of EUR 74.40. In two identical judgments dated 23 May 2023 (case no. II ZR 219/21 and II ZR 220/21), the German Federal Court of Justice (BGH) ruled in favor of two plaintiffs pursuant to sections 31 (5) and (6) WpÜG, referring to the principles of the so-called Celesio case law. In principle, all former shareholders of Stada AG who had initially exchanged their regular shares for the securities tendered for sale with ISIN DE000A2GS5A4 or for securities subsequently tendered for sale with ISIN DE000A2GS5B2 and had subsequently tendered these in the takeover offer are entitled for the payment of the difference.
Following a request of the Federal Financial Supervisory Authority („BaFin“) , the Bidder published a corresponding notice in the Federal Gazette, but pointed out that, in its view, any payment claims by former shareholders could be based on the defense of the statute of limitations. In the opinion of the Bidder, the statute of limitations generally began at the latest at the end of 2017. However, this is incorrect. The claims of the former shareholders of STADA are not yet time-barred: This is because after the courts of the 1st and 2nd instance had still rejected the claim for subsequent payment, only the BGH confirmed this claim for additional payment. The claim for additional payment is therefore not yet time-barred.
The SdK advises all affected shareholders to join a lawsuit initiated by the SdK in order to enforce their claims in court in cooperation with a renowned law firm. Former shareholders can register free of charge and without obligation at www.sdk.org/stada and will then receive all information on the proceedings.
The SdK will be happy to answer any questions from its affected members by e-mail at info@sdk.org or by telephone on +49 89 20208460.
Munich, February 08, 2023
SdK Schutzgemeinschaft der Kapitalanleger e.V.
--------------------
Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com --------------------